[Report on the 43rd Congress of the American Society for Therapeutic Radiology and Oncology (ASTRO), San Francisco, 4-8 November 2001].
Noël
G
G
Centre de protonthérapie, BP 65, 91402 Orsay, France. noel@ipno.in2p3.fr
Mazeron
J J
JJ
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001918:Brachytherapy; D001943:Breast Neoplasms / Q000532:radiotherapy; D001984:Bronchial Neoplasms / Q000532:radiotherapy; D003110:Colonic Neoplasms / Q000532:radiotherapy; D003131:Combined Modality Therapy; D016889:Endometrial Neoplasms / Q000532:radiotherapy; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D008223:Lymphoma / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000532:radiotherapy; D011182:Postoperative Care; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D018787:Radiation Oncology; D011879:Radiotherapy Dosage; D016032:Randomized Controlled Trials as Topic; D012004:Rectal Neoplasms / Q000532:radiotherapy; D012509:Sarcoma / Q000532:radiotherapy; D012955:Societies, Medical; D013997:Time Factors; D014481:United States; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy
D000970:Antineoplastic Agents